SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-005915
Filing Date
2018-04-30
Accepted
2018-04-30 07:46:29
Documents
125
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm 20-F 3163705
2 ex1-1.htm EX-1.1 108690
3 ex11-1.htm EX-11.1 72019
4 ex12-1.htm EX-12.1 16744
5 ex12-2.htm EX-12.2 17950
6 ex13-1.htm EX-13.1 7514
7 ex13-2.htm EX-13.2 7590
8 image_007.jpg GRAPHIC 53898
9 image_001.jpg GRAPHIC 42605
10 image_002.jpg GRAPHIC 43036
11 image_003.jpg GRAPHIC 25637
12 image_008.jpg GRAPHIC 156096
13 image_009.jpg GRAPHIC 20731
  Complete submission text file 0001493152-18-005915.txt   10488638

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE bfra-20171231.xml EX-101.INS 1688063
15 XBRL SCHEMA FILE bfra-20171231.xsd EX-101.SCH 120719
16 XBRL CALCULATION FILE bfra-20171231_cal.xml EX-101.CAL 82569
17 XBRL DEFINITION FILE bfra-20171231_def.xml EX-101.DEF 306901
18 XBRL LABEL FILE bfra-20171231_lab.xml EX-101.LAB 624258
19 XBRL PRESENTATION FILE bfra-20171231_pre.xml EX-101.PRE 433510
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Filer) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38396 | Film No.: 18786728
SIC: 2834 Pharmaceutical Preparations